Daily Stock Opinions and Ratings

Opinions

Michael Simpson, CFA KCP Income Fund KCP.UN-T BUY Mar 31, 2006

Originally they were in the private label bleach but have expanded to other consumer products as well as health/beauty care. Sees more growth on the pharmaceutical and healthcare side. Management has done a good job.

Michael Simpson, CFA

Owned

Unlock Rating

$10.480

Stock price when the opinion was issued

investment companies funds

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Bleach manufacturer. Once Clorox hedges come off they will be able to raise their prices. Recently diversified into the consumer health sector by becoming a contract manufacturer for Johnson & Johnson (JNJ-N), Pfizer (PFE-N), etc. Distribution of 10.6%.

WEAK BUY

Somewhat aggressive name. Made some good moves in the past. Ran into difficulties a couple of years ago and cut their distributions. Have since made acquisitions and grown their business. Subject to rising raw material costs which could affect them negatively.

BUY

Good management team. Would stand up through a recession.

BUY

A very good manufacturer of no name products and custom manufacturer for large corporations. He tends to buy during dips like this.

WEAK BUY

One of the largest producers of private label bleach products. Very tight margins. Well run and has a good future, but watch for volatility on the profit line. 13.5% yield.

DON'T BUY

Yield is now approaching above 13%. A stock that does very well in strong manufacturing times, but pull back when things slow. Payout may be vulnerable over the next while.

PAST TOP PICK

(A Top Pick April 26/06. Down 21.3%.) Had looked on this as a turn around play and their bleach business has turned around nicely. Acquisition of the custom manufacturing business has been disappointing.

HOLD

Had some concerns about the operating fundamentals and sold for holdings last summer. A relatively well run business and with pressure coming off from resin prices, operating picture should start to improve.

COMMENT

Have an extraordinary amount of currency exposure and stand to benefit from the weakening Cdn$. Had a pretty substantial price move over the last month. Have put them selves up for sale, but would be surprised if it sold for more than its current price. Expect it will weaken.

BUY

Had some problems, but with healthcare issues and reduced raw material input costs, he thinks problems can be fixed. Management is looking to cut costs. Payout ratio of about 95%. Has a bit higher debt level then he likes. Cheap.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Michael Simpson, CFA KCP Income Fund KCP.UN-T BUY Mar 31, 2006

You might be interested:

KCP Income Fund(KCP.UN-T)

KCP Income Fund(KCP.UN-T)

KCP Income Fund(KCP.UN-T)

KCP Income Fund(KCP.UN-T)

KCP Income Fund(KCP.UN-T)

KCP Income Fund(KCP.UN-T)

KCP Income Fund(KCP.UN-T)

KCP Income Fund(KCP.UN-T)

KCP Income Fund(KCP.UN-T)

KCP Income Fund(KCP.UN-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Stockchase Insights

Jim Cramer - Mad Money

Dan Rohinton

Richard Fogler

The Panic-Proof Portfolio (Stockchase Research)